Why is there a Dispensing Limitation on the drugs Ambien and Lunesta?
When originally introduced to market, Ambien and its generic, zolpidem, were FDA-approved for short-term use, which was defined as 7 to 10 days. As more medications to treat insomnia were introduced, including Lunesta, the FDA-approval language was broadened for the newer agents, allowing for long-term use. However, in analyzing the utilization of these agents, most filling members were using these medications on a short-term, episodic basis. The decision to apply the Dispensing Limitation of 10 units/30 days to all drugs in this category was based on prescribing trends within the Tufts Health Plan network. If you are attempting to obtain more then the Dispensing Limitation allows, you should first consult with your doctor. If your doctor determines that such a request is appropriate, then he/she must request approval from Tufts Health Plan in order for you to be covered for an amount over the Dispensing Limitation. Your doctor can request this by faxing a Universal Pharmacy Form to th
